EMERGING AGENTS IN BREAST CANCER CARE

ESMO
9/21/21, 8:30 PM
Europe/Paris GMT+2

Description

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

David Miles

Welcome and Introductions, A new era of next generation therapies in HER2-positive breast cancer, Breakthrough developments in triple-negative breast cancer, HR-positive breast cancer: emerging trends in cancer treatment, Panel discussion and live Q&A, Summary and close

Inglês

 

Speakers

Mark Pegram, Seock-Ah Im, Erika Hamilton